It is a great pleasure to invite you to be part of the 14th International Congress on SLE, in Venice, Italy which will be held on October 6-9, 2021 together with the 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA).
In 2021, the world of SLE will be at a crossroads. Advances in technology mean that it is now possible to address virtually any biological target with a specific therapy. Across diseases like rheumatoid arthritis and many types of cancer, this has meant life-changing and life-saving new therapies, while a similar progress has been frustratingly slower in SLE. However, laboratory research, bench-to-bedside approach with translation of novel discoveries into therapeutic agents, and the ability to successfully evaluate new molecules in clinical trials, have accelerated dramatically in recent years, rejuvenating a solid hope among researchers and physicians who care about SLE patients. Application of the treat-to-target strategy to SLE was made possible by the joint effort of experts to pinpoint the most promising targets to treat patients to, leading to optimization of available treatments. Additionally, precision medicine is emerging nowadays in SLE, highlighting the need of committing basic research to a clinical applicability, thereby creating an inseparable duo between scientific progress and improvement of patients prognosis, gathering together different expertise and altogether offering to the scientific SLE community, as well as to drug developers and patients, a good reason to believe in a ‘new dawn’ of SLE management.
The LUPUS 2021 Congress will showcase the very best clinical, biological, and translational advances in the field of SLE and autoimmunity. The Congress will include an exceptional program focusing on the nexus between laboratory science and clinical translation, include multidisciplinary sessions on topics from B cells to nephritis, and offer a unique opportunity for the presentation of original data.
The CORA 2021 will cover controversial topics relating to clinical diagnosis, management, and pathogenesis of rheumatic and autoimmune disorders including rheumatoid arthritis, psoriatic arthritis, spondyloarthropathies, systemic sclerosis, fibromyalgia as well as therapeutic issues such as biologics and biosimilars. All the highly controversial and burning issues will be discussed in the intuitive and theatrical debate sessions where scientists fight each other in order to actively defend their own convictions
The chance of holding a meeting with a twin soul by joining the Lupus with the CORA meeting will not only widen the topics panorama, but will provide the chance of dissecting critical issues in detail, accommodating debates and different points of view explained by selected experts, thereby summarizing current data and exploring different faces of complex autoimmune systemic diseases.
We are delighted to have this conference taking place in Venice – a symbol for the whole country and the capital of northern Italy’s Veneto region, which is built on more than 100 small islands in a lagoon in the Adriatic Sea.
Few cities can claim such a priceless art and history heritage as Venice. This unique city with its magical, spectacular scenery is not just beautiful; it is a real miracle of creative genius where culture, architecture, art and commerce could could flourish on the slime of an inhospitable landscape, thereby successfully overcoming the surrounding hurdles and establishing a prosperous balance lasting until today.
Therefore, I most cordially invite you to join us in Venice, at the 14th International Congress on SLE in 2021, in collaboration with the 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA), and make an incomparable difference.
Prof. Andrea DoriaLUPUS & CORA 2021 Congress Chair
Andrea Doria is Professor of Rheumatology and Head of the Rheumatology Unit and Unit of Connective Tissue Disease and Rare Rheumatic Diseases, Department of Medicine, University of Padua, Italy.
Professor Doria received his medical degree and qualification in Rheumatology from the University of Padua. He was Council member of the Italian College of Rheumatology (CRO) between 1999 and 2005 and a Council member of the Italian Society of Rheumatology (SIR) from 2007 to 2010 and from 2013 to present. He is also a member of American College of Rheumatology (ACR).
He has authored over 300 ISI publications on SLE and other connective tissue diseases.
In addition, he has authored and co-authored three books, over 90 book chapters and conference proceedings, and over 700 abstracts for national and international conferences.